The 3 E’s of ICI in Endometrial Cancer: Emergence, Evolution, and Expansion, an Industry Supported Symposium at IGCS 2023

Activity Overview

GSK welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to register for access to The 3 E’s of ICI in Endometrial Cancer: Emergence, Evolution, and Expansion Enduring Education Materials, an Industry Supported Symposium at the IGCS 2023 Annual Global Meeting in Seoul, South Korea.

Join a panel of international experts for an educational program on the emergence, evolution, and expansion of immune checkpoint inhibitors (ICIs) in endometrial cancer (EC).

Our Chair, Dr. Byoung-Gie Kim, will review the unmet needs and recent advances in EC, including the current Asian management guidelines for improved management of EC patients.

Dr. Jung-Yun Lee will discuss the emergence of PD-1 inhibitors, either as monotherapy or in combination with a tyrosine kinase inhibitor, and the impact on outcomes in patients with recurrent EC. Dr. Lee will further review irAE management in these patients.

Dr. Mansoor Mirza will discuss the recent evolution in evidence for the treatment of patients with primary advanced/recurrent EC with anti-PD(L)1 therapies, giving an overview of recent data from Phase 3, randomized trials of PD-(L)1 inhibitors plus chemotherapy in this population.

Our final panelist, Dr. David SP Tan, will provide an overview of how ICIs are being studied in combination with PARP inhibitors, ADCs, and other targeted therapies for the treatment of advanced/recurrent EC. Attendees will gain an appreciation for the rationale for evaluating these combinations and the ongoing trials in this space.

Target Audience

The target audience for this activity is community and academic gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other providers who treat patients with gynecologic malignancies.

Moderator


Dr. Byoung-Gie Kim

Faculty


Dr. Jung-Yun Lee

Dr. Mansoor Raza Mirza

Dr. David SP Tan

Agenda & Presentation Materials

The 3 E’s of ICI in Endometrial Cancer: Emergence, Evolution, and Expansion, an Industry Supported Symposium at the IGCS 2023 Annual Global Meeting

Presented on Monday, November 6, 2023 from 12:40 – 14:10 KST

Enduring Education Materials will be available until August 2024.

Register To Access the Symposium Recording

12:40 – 12:50 KIST
Foundations of the EC management landscape – View Presentation
Byoung-Gie Kim, MD, PhD (Chair), Republic of Korea
12:50 – 13:05 KIST
Emergence of ICI: monotherapy and TKI combination for treatment of advanced/recurrent EC – View Presentation
Jung-Yun Lee, MD, PhD, Republic of Korea
13:05 – 13:35 KIST
Evolution of ICI combinations: ICI + chemotherapy for treatment of primary advanced/recurrent EC – View Presentation
Mansoor Raza Mirza, MD, Denmark
13:35– 14:00 KIST
Expansion of ICI: investigating combination with PARPi or TKI and beyond for treatment of primary advanced/recurrent EC – View Presentation
David SP Tan, MBBS, PG Dip, MRCP, PhD, FRCP, Singapore
14:00 – 14:10 KIST
Panel discussion, Q & A from audience and concluding remarks – View Presentation
All Faculty

Technical Requirements

The virtual live broadcast is best experienced using the most current browser (or one back) of Firefox, Chrome, Safari, Internet Explorer, or Microsoft Edge. For all activities featuring audio you must have a sound card and speakers.